Lifeway Foods (LWAY) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Achieved record net sales of $63.0 million for Q1 2026, a 36.7% year-over-year increase, marking the 26th consecutive quarter of growth.
Net income rose 32% year-over-year to $4.7 million, with EPS of $0.31 basic and $0.30 diluted.
Growth was volume-led, driven by flagship kefir and Farmer Cheese products, supported by consumer trends toward protein-rich, probiotic foods.
Expanded brand visibility through strategic partnerships, experiential marketing, and new product launches.
Remains the largest U.S. producer of kefir and continues to focus on health and wellness trends.
Financial highlights
Net sales: $63.0 million (up from $46.1 million year-over-year), surpassing the $60 million threshold for the first time.
Gross profit margin expanded to 27.5%, up 360 basis points from 23.9% last year.
Net income: $4.7 million (up from $3.5 million year-over-year); EPS (diluted): $0.30 (up from $0.23 year-over-year).
Operating income reached $6.3 million, up from $1.6 million in Q1 2025.
SG&A expenses totaled $10.9 million, a 16.8% increase, but leveraged 300 basis points as a percentage of revenue.
Outlook and guidance
Waukesha facility expansion remains on track, expected to double capacity by Q4 2026 and be fully online in Q1 2027.
Management expects continued strong liquidity from operations, credit facility, and cash reserves.
Reiterated long-term target of $45–$50 million in Adjusted EBITDA for FY 2027.
Investments in manufacturing, marketing, and innovation are expected to drive sustainable, profitable growth.
No material adverse impact from macroeconomic conditions is anticipated.
Latest events from Lifeway Foods
- All proposals passed, with strong growth, innovation, and expanded distribution highlighted.LWAY
AGM 202617 Jun 2026 - Shareholders will vote on eight board nominees, including Jason Scher, and key annual proposals.LWAY
Proxy filing3 Jun 2026 - Proxy covers director elections, auditor ratification, and executive pay, highlighting governance and ESG.LWAY
Proxy filing1 May 2026 - Votes will be cast on board elections, auditor ratification, and executive pay at the 2026 meeting.LWAY
Proxy filing30 Apr 2026 - Record sales and profit growth, margin expansion, and innovation drive strong 2026 outlook.LWAY
Q4 202517 Mar 2026 - Q2 net sales rose 25.3% to $49.2M, net income hit $3.8M, and all debt was repaid.LWAY
Q2 20241 Feb 2026 - Q3 2024 sales up 12.7%, net income $3M, global expansion, and Danone bid rejected.LWAY
Q3 202414 Jan 2026 - ISS backs the full board slate for the 2025 meeting, urging shareholders to vote accordingly.LWAY
Proxy Filing19 Dec 2025 - Up to 3.45 million shares are being resold by a major shareholder as part of a governance agreement.LWAY
Registration Filing16 Dec 2025